News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bluebird bio to Present at UBS Global Life Sciences Conference


9/13/2012 10:14:54 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that Nick Leschly, CEO of bluebird bio, is scheduled to present at the UBS Global Life Sciences Conference on Thursday, September 20, 2012 at 10:00AM ET in New York City.

Read at BioSpace.com


comments powered by Disqus
UBS
bluebird bio
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES